Intellectual Property India Publishes Patent Application for '6-Fluoro-2-(3-Nitrophenyl)-1h-Benzo[D]Imidazole As Anticancer And Process For The Preparation There Of' Filed by Dr. Nitin A. Sasane; Dr. Kulbhushan A. Sasane; Dr. Vikas V. Borge; Dr. Satish B. Manjare; Dr. Gangadhar A. Meshram; Dr. Ambareen P. Shaikh; and Dr. Bhushan B. Popatkar

MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202621024620 A) filed by Dr. Nitin A. Sasane; Dr. Kulbhushan A. Sasane; Dr. Vikas V. Borge; Dr. Satish B. Manjare; Dr. Gangadhar A. Meshram; Dr. Ambareen P. Shaikh; and Dr. Bhushan B. Popatkar, Maharashtra, on March 2, for '6-fluoro-2-(3-nitrophenyl)-1h-benzo[d]imidazole as anticancer and process for the preparation there of.'

Inventor(s) include Dr. Nitin A. Sasane; Dr. Kulbhushan A. Sasane; Dr. Vikas V. Borge; Dr. Satish B. Manjare; Dr. Gangadhar A. Meshram; Dr. Ambareen P. Shaikh; and Dr. Bhushan B. Popatkar.

The application for the patent was published on May 1, under issue no. 18/2026.

According to the abstract released by the Intellectual Property India: "The current invention offers a compound of general formula (A) are useful as potential anti-cancer agents against human breast cancer cell lines MCF-7 and process for the preparation thereof."

Disclaimer: Curated by HT Syndication.